Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XBI vs IBB overlap: 4% of top holdings shared

Bottom line

How much do XBI and IBB overlap?

4% of their top holdings overlap by weight. 2 securities appear in both funds' top 25, making up 2.6% of XBI's assets and 3.0% of IBB's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

XBIIBB
Weight overlap (top 25)4%
Shared holdings2
Weight in shared holdings2.6%3.0%
Total positions161254
Expense ratio0.35%0.44%
Holdings as ofJun 30, 2026Sep 30, 2025

Source: SEC Form N-PORT (periods Jun 30, 2026 / Sep 30, 2025)

Holdings XBI and IBB have in common

Holding% of XBI% of IBBOverlap
Moderna Inc1.41%0.88%0.88%
Natera Inc1.16%2.11%1.16%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Sep 30, 2025)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XBI

  1. State Street Global Advisors — 5.87%
  2. Apogee Therapeutics Inc — 1.49%
  3. Twist Bioscience Corp — 1.41%
  4. Oruka Therapeutics Inc — 1.38%
  5. Kymera Therapeutics Inc — 1.36%
  6. Viking Therapeutics Inc — 1.30%
  7. Praxis Precision Medicines Inc — 1.29%
  8. Erasca Inc — 1.27%
  9. Revolution Medicines Inc — 1.20%
  10. Rhythm Pharmaceuticals Inc — 1.20%
  11. CG oncology Inc — 1.20%
  12. SELLAS Life Sciences Group Inc — 1.19%
  13. Vaxcyte Inc — 1.19%
  14. Dianthus Therapeutics Inc — 1.18%
  15. Cytokinetics Inc — 1.18%

Only in IBB

  1. BlackRock Funds III — 13.18%
  2. Vertex Pharmaceuticals, Inc. — 7.66%
  3. Gilead Sciences, Inc. — 7.52%
  4. Amgen, Inc. — 7.50%
  5. Regeneron Pharmaceuticals, Inc. — 5.70%
  6. Alnylam Pharmaceuticals, Inc. — 5.68%
  7. IQVIA Holdings, Inc. — 3.18%
  8. Argenx SE — 3.15%
  9. Insmed, Inc. — 2.95%
  10. Mettler-Toledo International, Inc. — 2.49%
  11. BeOne Medicines Ltd. — 2.11%
  12. Biogen, Inc. — 2.03%
  13. United Therapeutics Corp. — 1.82%
  14. Waters Corp. — 1.77%
  15. Incyte Corp. — 1.62%

Asset mix

Asset typeXBIIBB
Stocks99.9%99.8%
Cash & short-term funds5.9%13.4%
Equity derivatives0.1%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Sep 30, 2025)

Country mix

CountryXBIIBB
US100.8%98.6%
NL1.0%4.3%
CH1.0%2.7%
DK—2.2%
IE1.2%0.5%
BM1.2%0.7%
GB—1.0%
KY—0.9%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Sep 30, 2025)

Check another pair

FAQ

How much do XBI and IBB overlap?
About 4% by weight. 2 securities appear in both funds' top 25 holdings; they make up 2.6% of XBI's assets and 3.0% of IBB's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do XBI and IBB have in common?
The largest shared holdings are Natera Inc, Moderna Inc.
Should I own both XBI and IBB?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, XBI or IBB?
IBB is broader, with 254 positions versus 161 for XBI. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.